Researchers in the School of Pharmacy’s Kwon Lab have been awarded a patent for a promising new therapy with implications for many conditions, such as kidney disease, heart failure, and even COVID-19.
Researchers in the School of Pharmacy’s Kwon Lab have been awarded a patent for a promising new therapy with implications for many conditions, such as kidney disease, heart failure, and even COVID-19.
In collaboration with oncology professor Wei Xu, professors Lingjun Li and Weiping Tang are developing tools to tackle breast cancers that no longer respond to traditional therapies.
Here are 3 things to know about the Tang Lab’s work toward antiviral therapeutics targeting a broad range of coronaviruses.
By combing the ocean for antimicrobials, scientists at the University of Wisconsin–Madison have discovered a new antifungal compound that efficiently targets multi-drug-resistant strains of deadly fungi without toxic side effects in mice.
AAPS recognizes the UW student chapter’s outstanding service and outreach By Tristan Dooley The American Association of Pharmaceutical Scientists (AAPS) selected UW–Madison School of Pharmacy as a 2020 AAPS Student Chapter Award winner. Only two …
History comes alive in this new five-day festival that brings new insights to today’s urgent questions By Tristan Dooley Fascinating topics in the social history of pharmacy and pharmaceuticals will be highlighted in 11 panels, …
The legacy of Professor Emeritus Dan Rich lives on at the School and in prolific alumni careers.
Professor Seungpyo Hong is the Chair’s first recipient, adding to a growing roster of alumni-supported professorships By Katie Ginder-Vogel The oldest son of dairy farmers, Milton Henrichs (BS ‘44) grew up north of Green Bay, …
New faculty members strengthen the School of Pharmacy’s research and education in pediatric pharmacy, drug delivery, and precision medicine.
Professor Weiping Tang harnesses cells’ natural protein disposal system to destroy disease-causing proteins.